unknown

Legal and executive headquarters are in Galway, Ireland, while operational headquarters are in Minneapolis, Minnesota, U.S.  All Ireland companies → — Founded 1949
Healthcare Conglomerate Medical Device / Hardware
Gastroenterology
Clinical Decision Support & Reference Gastroenterology AI
Public (listed on NYSE: MDT) — Medtronic has raised an undisclosed amount in funding over 16 rounds. Some sources indicate a total funding of $1.8 billion over 10 rounds, with the latest round being $1.8 billion in September 2025. Other sources mention a total funding of $367 million.
Website Claim this company

Products

AI Symptom Checker
unknown
Clinical Decision Support & Reference
Doctronic's AI Symptom Checker combines cutting-edge artificial intelligence with clinical accuracy to transform healthcare by assisting physicians with preliminary patient assessments.
AI-Powered OBGYN & Gynecologic Consultations
unknown
Clinical Decision Support & Reference
Doctronic's AI-Powered OBGYN & Gynecologic Consultations offer fast, personalized guidance for menstrual health, pregnancy support, UTIs, and reproductive care.

See all 2 products →

About unknown

Medtronic is a global leader in healthcare technology, dedicated to alleviating pain, restoring health, and extending life. The company develops and manufactures a vast array of medical devices and therapies, ranging from pacemakers and insulin pumps to advanced robotic-assisted surgery systems and AI-driven diagnostic tools. Medtronic operates in more than 150 countries and employs over 90,000 people.

For physicians, Medtronic offers solutions across four main portfolios: Cardiovascular, Neuroscience, Medical Surgical, and Diabetes. The company is actively integrating AI and data analytics into its technologies to empower clinicians with individualized treatment plans and improve outcomes. Examples of AI applications include computer-aided detection systems for colonoscopies (GI Genius™) to identify polyps, advanced algorithms in pulse oximeters (Nellcor™) for reliable readings, and AI-powered systems (AiBLE™) to enhance accuracy and planning in robotic-assisted surgeries, particularly for delicate spine procedures. Medtronic also utilizes AI in cardiac care with AccuRhythm™ AI algorithms to filter false alerts and provide clear data for heart monitoring. The company is committed to the responsible and ethical use of AI in healthcare, guided by its AI Compass framework.

Focus Areas

Medtronic focuses on developing and manufacturing healthcare technologies and therapies for over 70 chronic diseases and conditions. Key focus areas include: Cardiovascular (cardiac rhythm management interventional cardiology cardiac surgery peripheral vascular health structural heart and aortic) Neuroscience (cranial and spinal technologies neuromodulation neurovascular pelvic health and gastric therapies ear nose and throat) Medical Surgical (surgical endoscopy acute care and monitoring) and Diabetes. The company is also heavily invested in leveraging artificial intelligence data analytics and robotic-assisted surgery across these areas to improve diagnostics treatment planning and surgical precision.

Business Intelligence

Key InvestorsVanguard Capital Management LLC, STATE STREET CORPORATION, JPMorgan Investment Management, Inc., Capital Research & Management Co. (Global Investors), Blackrock Inc.
PartnershipsPrecision Neuroscience (brain-computer interface), GE HealthCare (intraoperative ultrasound integration), NVIDIA (AI platform for medical devices)
AcquisitionsCovidien (2015), Bellco (2016), HeartWare International Inc. (2016), Crospon (2017), Mazor Robotics (2018), Nutrino Health Ltd (2018), Titan Spine (2019), Klue (2019), Stimgenics, LLC (2020), Medicrea (2020), Companion Medical (2020), Avenu Medical (2020), Digital Surgery (2020), Intersect ENT (2022), Affera, Inc. (2022), Scientia Vascular (2026), CathWorks (2026), SPR Therapeutics (2026)
TechnologyCloud-based digital portal (GAiTEWAY™ platform for spine surgery), AI-enabled capabilities (Stealth AXiS surgical system), Open-source technology platform (SPICE for data-driven, community-based healthcare delivery), NVIDIA Holoscan and IGX (real-time AI computing software platform for medical devices), Touch Surgery™ Ecosystem (digital technologies for surgical workflow, video, simulations, case management)
FDA ClearancesMultiple (specific total number not provided, but several recent clearances mentioned) cleared products (estimated)

What Physicians Need to Know

Cardiovascular
Medtronic offers a comprehensive portfolio for cardiovascular health, including cardiac rhythm management (pacemakers, ICDs, CRT devices, insertable cardiac monitors), interventional cardiology (catheters, stents), cardiac surgery, peripheral vascular health, structural heart, and aortic therapies. They have developed world-first technologies like wearable and implantable pacemakers and remote patient monitoring systems. Their AccuRhythmu2122 AI algorithms improve the accuracy of alerts from insertable cardiac monitors, particularly for atrial fibrillation and asystole. Medtronic recently acquired CathWorks to integrate AI-powered coronary technology.
Neuroscience
Medtronic's neuroscience focus includes cranial and spinal technologies, neuromodulation, neurovascular, pelvic health, gastric therapies, and ear, nose, and throat solutions. They are a leader in deep brain stimulation (DBS) for conditions like Parkinson's disease, offering the Perceptu2122 family of neurostimulators with BrainSenseu2122 technology. BrainSenseu2122 technology provides real-time insights into a patient's brain signals, allowing for personalized and adaptive DBS therapy. Medtronic is also integrating brain-computer interfaces with their surgical navigation systems, such as the StealthStation, through partnerships like the one with Precision Neuroscience.
Medical Surgical
This area encompasses surgical, endoscopy, acute care, and monitoring solutions. Medtronic offers innovative surgical robotics, including the Hugou2122 Robotic-Assisted Surgery (RAS) system, designed for precision and versatility in soft-tissue surgeries. Their Touch Surgeryu2122 Enterprise platform allows surgeons to access and analyze surgical footage, facilitating learning and improvement. The Signiau2122 stapling system utilizes Adaptive Firingu2122 and Adaptive Compressionu2122 technologies for consistent staple lines. Medtronic's GI Geniusu2122 intelligent endoscopy module uses AI to detect lesions during colonoscopies, improving early detection of colorectal cancer.
Diabetes
Medtronic provides integrated systems for diabetes management, including insulin pumps and continuous glucose monitoring (CGM). Key products include the MiniMedu2122 780G system, a closed-loop insulin pump that automates insulin delivery and correction boluses, and the InPenu2122 smart insulin pen for those on multiple daily injections. They also offer the CareLinku2122 Clinic therapy management software for healthcare professionals. Medtronic is actively developing AI-powered solutions like the Sugar.IQ app, which acts as a 'personal diabetes assistant' by recognizing patterns in diabetes data.
Artificial Intelligence & Data Analytics
Medtronic heavily leverages AI and data analytics across its focus areas to improve diagnostics, treatment planning, and surgical precision. They have a global hub for AI and robotics in surgery in London, focusing on developing AI and digital technologies. Examples include AI algorithms for cardiac monitoring (AccuRhythmu2122), AI-powered decision support for surgeons (AiBLEu2122 system), and intelligent endoscopy modules (GI Geniusu2122). AI is also used in surgical education and performance through the Touch Surgeryu2122 ecosystem.
Robotic-Assisted Surgery
Medtronic is a leader in robotic-assisted surgery with systems like the Hugou2122 RAS system, which aims to transform surgery through precision and technology. These systems are designed to provide unparalleled access and precision in complex spine, cranial, and minimally invasive soft-tissue surgeries. The company emphasizes modular and upgradeable systems, compatibility with existing instrumentation, and analytics to inform decision-making.
Physician Tip

Medtronic emphasizes strong collaboration with physicians in developing and advancing therapies, recognizing their vital role in clinical insights, technology development, and educating other healthcare professionals. They offer educational resources, training opportunities, and patient-reported outcomes (PRO) software services to support physicians in optimizing patient care. Medtronic also provides direct access to product and clinical experts through their Connect.MeSM Remote Sales team, offering specialist guidance and informative product support. The company is committed to ethical collaboration and transparency regarding physician compensation.

Medtronic's technology stack for platforms like SPICE utilizes modern web technologies such as React, HTML5, SCSS, TypeScript, and npm for the presentation layer, and PostgreSQL for robust data storage. They also leverage Fast Healthcare Interoperability Resources (FHIR) for seamless exchange of health data between different healthcare systems, supporting interoperability, scalability, and ease of implementation. Medtronic's systems are designed to integrate AI and data analytics to provide real-time insights and personalized care across various devices and platforms, such as the integration of BrainSenseu2122 technology with DBS systems and AI algorithms with cardiac monitors.

Products by unknown

2 products in the directory

AI Symptom Checker
unknown
Clinical Decision Support & Reference
Doctronic's AI Symptom Checker combines cutting-edge artificial intelligence with clinical accuracy to transform healthcare by assisting physicians with preliminary patient assessments.
AI-Powered OBGYN & Gynecologic Consultations
unknown
Clinical Decision Support & Reference
Doctronic's AI-Powered OBGYN & Gynecologic Consultations offer fast, personalized guidance for menstrual health, pregnancy support, UTIs, and reproductive care.

What the Web Says

Medtronic receives mixed reviews, with many employees praising its mission-driven culture, opportunities for growth, and good compensation and benefits. However, some employees express concerns about frequent layoffs, repetitive work, and management issues. Product reviews, particularly for their diabetes management systems, are also mixed, with some users finding them life-changing while others report significant issues with sensor accuracy, pump design, and customer service.

Overall: Mixed

Strengths

  • Strong company mission and patient-focused approach.
  • Opportunities for growth and advancement.
  • Good compensation and benefits.
  • Supportive and inclusive work environment.
  • Innovative products that can improve quality of life (e.g., 780G system for diabetes).
  • Improved sleep and reduced mental burden for some users of diabetes management systems.
  • Work-life balance is respected.
  • Ability to work from home for some roles.

Limitations

  • Frequent layoffs and job insecurity.
  • Repetitive work in some production roles.
  • Management issues and lack of proper communication.
  • Outdated technology and hardware issues with some products (e.g., older insulin pumps and CGMs).
  • Poor sensor accuracy and reliability for some diabetes management systems.
  • Subpar customer service and technical support for product issues.
  • Bulky and awkward pump design.
  • Slow to implement changes and bureaucratic processes.

Based on reviews from: Indeed.com, Comparably, PayScale, Pumps & Pricks, Reddit, Trustpilot, MiniMed, Mayo Clinic Connect, G2, Capterra, Teamlyzer, REVIEWS.io, Quora

Last updated: 2026-07-12

Videos

News, demos, and interviews about unknown.

Loading videos...

Videos load interactively. If none appear, search YouTube for unknown →

View all on YouTube

Press & Coverage

Medtronic Newsroom
Medtronic completes acquisition of Scientia Vascular, seamlessly integrating access and therapeutic portfolios for neurovascular care
Medtronic announced the completion of its acquisition of Scientia Vascular, aiming to integrate access and therapeutic portfolios for neurovascular care. This acquisition is expected to enhance Medtronic's offerings in the neurovascular space.
2026-06
Medtronic Newsroom
Medtronic submits 510(k) filings to expand Hugou2122 robotic-assisted surgery system into general and gynecologic specialties in the United States
Medtronic has submitted 510(k) filings to the FDA to expand the use of its Hugou2122 robotic-assisted surgery system into general and gynecologic specialties in the U.S. This move aims to broaden the application of the Hugo system beyond its initial indications.
2026-06
Medtronic Newsroom
Medtronic announces strategic investments to support future expansion of cardiac ablation portfolio as physician demand for Afferau2122 technologies broadens
Medtronic announced strategic investments to support the expansion of its cardiac ablation portfolio, driven by increasing physician demand for Afferau2122 technologies. These investments highlight Medtronic's commitment to growth in the cardiac ablation business.
2026-06
Medtronic Newsroom
Medtronic reports fourth quarter and full year fiscal 2026 results; delivers highest annual revenue growth in 10 years
Medtronic reported its fourth quarter and full fiscal year 2026 results, achieving its highest annual revenue growth in 10 years. This performance is attributed to disciplined execution and portfolio strength.
2026-06
Healthcare Dive
Medtronic starts to notify people affected by cyberattack
Medtronic has begun notifying individuals potentially affected by a cyberattack disclosed over two months prior, though the company states there is no evidence the accessed data has been publicly posted. The company is offering credit monitoring and identity theft restoration services.
2026-07
Security Affairs
Medtronic Notifies 3.8 Million After ShinyHunters Data Breach
Medtronic is notifying over 3.8 million individuals about a data breach linked to the ShinyHunters extortion group, which exposed personal and medical information. The company confirmed the cyberattack on its corporate IT systems in April 2026.
2026-07
Medtronic Newsroom
Medtronic study reveals AI-enabled clinician alerts significantly improve evaluation and valve intervention for patients with heart valve disease
A Medtronic-sponsored study, the ALERT Trial, demonstrated that AI-enabled electronic clinician notifications significantly improve the timely evaluation and treatment of aortic stenosis and mitral regurgitation. These findings were presented at the American College of Cardiology Annual Scientific Sessions.
2026-03
Medtronic Newsroom
Medtronic receives FDA clearance for Nellcoru2122 pulse oximetry system with Nell-EQu2122 intelligent processor, a new technology designed to improve reliability across diverse patients and conditions
Medtronic received FDA clearance for its Nellcoru2122 pulse oximetry system featuring the Nell-EQu2122 intelligent processor, a new technology aimed at improving reliability across diverse patient populations and conditions. This clearance expands Medtronic's Acute Care & Monitoring portfolio.
2026-06

Frequently Asked Questions

Medtronic offers a broad portfolio of medical devices and therapies across several key areas, including Cardiovascular (e.g., pacemakers, stents, heart valves), Neuroscience (e.g., spinal implants, neurostimulators, neurovascular devices), Medical Surgical (e.g., surgical instruments, endoscopy systems, patient monitoring), and Diabetes (e.g., insulin pumps, continuous glucose monitoring systems). They also integrate AI, data analytics, and robotic-assisted surgery to enhance these offerings.
Medtronic is committed to rigorous compliance and patient safety. They adhere to global regulatory standards, including FDA regulations and CE marking requirements, throughout the entire product lifecycle, from design and manufacturing to post-market surveillance. The company also invests heavily in clinical trials and quality control processes to ensure the efficacy and safety of their products.
Medtronic's pricing structure varies depending on the specific device, therapy, and volume of purchase. They aim to provide competitive pricing while reflecting the advanced technology and clinical value of their products. For detailed pricing information and comparisons, it's best to contact a Medtronic sales representative directly to discuss specific needs and potential contracting options.
Medtronic offers comprehensive clinical and technical support for its products. This includes dedicated field representatives, clinical specialists for training and case support, technical support hotlines, and extensive educational resources. They also provide ongoing training and professional development programs for healthcare professionals to ensure optimal use of their technologies.
Yes, Medtronic actively engages in partnerships with healthcare providers, academic institutions, and research organizations. These collaborations often focus on advancing medical research, developing new therapies, improving patient outcomes, and optimizing healthcare delivery. They also partner to integrate their technologies into broader healthcare solutions.
Medtronic is a well-established global leader in medical technology with a strong financial foundation and a long-term vision focused on innovation and improving human health. They continuously invest in research and development, strategic acquisitions, and emerging technologies like AI and robotics to maintain their market leadership and ensure sustained growth and stability.
Medtronic is heavily invested in leveraging AI and data analytics across its portfolio to enhance diagnostics, personalize treatment planning, and improve surgical precision. This includes developing AI-powered algorithms for image analysis, predictive analytics for patient management, and data-driven insights to optimize device performance and clinical workflows.

Related Companies

CAIMed (Niedersächsisches Zentrum für KI und Kausale Methoden in der Medizin)
Hannover, Germany (Lower Saxony region)

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm
Berkeley, United States and London, United Kingdom. European office in Barcelona, Spain and Gothenburg, Sweden.

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA
London, UK

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Fraunhofer-Gesellschaft (Fraunhofer AICOS) / PALMX APPS LTD / Skin Analytics
London, United Kingdom

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI
Canberra, ACT, Australia

MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART
Boizenburg / Elbe, Germany

allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]
Suggest an Edit →
AI Tool Finder
AI-powered search. Results may not be comprehensive.